相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro effects of alendronate on fibroblasts of the human rotator cuff tendon
Chang-Meen Sung et al.
BMC MUSCULOSKELETAL DISORDERS (2020)
Influence of pH on osteoclasts treated with zoledronate and alendronate
Francisco Javier Manzano-Moreno et al.
CLINICAL ORAL INVESTIGATIONS (2019)
Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice
Anna M. Mattson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Bisphosphonate activation of crystallized bioglass scaffolds for enhanced bone formation
Boonlom Thavornyutikarn et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
A facile way for development of three-dimensional localized drug delivery system for bone tissue engineering
Ali Farzin et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Needleless emulsion electrospinning for the regulated delivery of susceptible proteins
Matej Buzgo et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)
Preparation and stability of dexamethasone-loaded polymeric scaffolds for bone regeneration processed by compressed CO2 foaming
Leticia Goimil et al.
JOURNAL OF CO2 UTILIZATION (2018)
Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions
Claire I. A. van Houdt et al.
SCIENTIFIC REPORTS (2018)
RELEVANCE OF OSTEOCLAST-SPECIFIC ENZYME ACTIVITIES IN CELL-BASED IN VITRO RESORPTION ASSAYS
A. Bernhardt et al.
EUROPEAN CELLS & MATERIALS (2017)
Follistatin-like 1 promotes osteoclast formation via RANKL-mediated NF-κB activation and M-CSF-induced precursor proliferation
Hyun-Ju Kim et al.
CELLULAR SIGNALLING (2016)
Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice
Kanako Tsuboi et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways
Shuyu Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Comparison of osteoclastogenesis and resorption activity of human osteoclasts on tissue culture polystyrene and on natural extracellular bone matrix in 2D and 3D
C. Kleinhans et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Effects of Alendronate on Osteoclast Formation and Activity In Vitro
Caroline A. Martins et al.
JOURNAL OF ENDODONTICS (2015)
Formation of Osteoclasts on Calcium Phosphate Bone Cements and Polystyrene Depends on Monocyte Isolation Conditions
Anne Bernhardt et al.
TISSUE ENGINEERING PART C-METHODS (2015)
The effect of alendronate on the expression of important cell factors in osteoclasts
Qinghong Zhang et al.
MOLECULAR MEDICINE REPORTS (2013)
Alendronate enhances osseous healing in a rat calvarial defect model
Hulya Toker et al.
ARCHIVES OF ORAL BIOLOGY (2012)
Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases
Jun Sun et al.
ARCHIVES OF ORAL BIOLOGY (2012)
M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
Jason M. Hodge et al.
PLOS ONE (2011)
Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages
Marco G. Cecchini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
7 Bisphosphonates for the treatment of osteoporosis: insights for clinicians
E. Michael Lewiecki
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2010)
Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis
Letizia Penolazzi et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: Time-dependent inhibition of human farnesyl pyrophosphate synthase
James E. Dunford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts
Vera de Fatima Padrao Correia et al.
DENTAL TRAUMATOLOGY (2006)
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis
K Thompson et al.
MOLECULAR PHARMACOLOGY (2006)
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
G. H. Nancollas et al.
BONE (2006)
Evidence that receptor activator of nuclear factor (NF)-κB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-κB-independent and TRAF6-dependent mechanism
AC Bharti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro
A Töyräs et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
O Kudo et al.
BONE (2003)
Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro
I Mathov et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Convergence of αvβ3 integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cγ in prefusion osteoclasts
I Nakamura et al.
JOURNAL OF CELL BIOLOGY (2001)
Osteoporosis influences the early period of fracture healing in a rat osteoporotic model
H Namkung-Matthai et al.
BONE (2001)
分享论文
